Delayed angioedema after administration of the severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine.

Watts, Melissa M; Maurer, Laura E; Grammer, Leslie C; Saltoun, Carol A; Stevens, Whitney W

Watts, Melissa M; Maurer, Laura E; Grammer, Leslie C; Saltoun, Carol A; Stevens, Whitney W.

Watts MM; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Maurer LE; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Grammer LC; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Saltoun CA; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
Stevens WW; Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: whitney-stevens@northwestern.edu.

Ann Allergy Asthma Immunol ; 128(2): 215-216, 2022 02.

Article in English | MEDLINE | ID: covidwho-1530597

Subject(s)

Angioedema; COVID-19 Vaccines/adverse effects; COVID-19; Adult; Angioedema/chemically induced; COVID-19/prevention & control; Female; Humans; Male; Vaccines, Synthetic/adverse effects; Young Adult; mRNA Vaccines/adverse effects

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Angioedema Type of study: Case report Topics: Vaccines Limits: Adult / Female / Humans / Male / Young adult Language: English Journal: Ann Allergy Asthma Immunol Journal subject: Allergy and Immunology Year: 2022 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google